GLAUKOS CORP.
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 907
- Market Cap
- $7.4B
- Website
- http://www.glaukos.com
Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents
- Conditions
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2017-12-18
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01252862
- Locations
- π¦π²
S.V. Malayan's Ophthalmology Centre, Yerevan, Armenia
A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent
- Conditions
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT01252914
- Locations
- π¦π²
S.V. Malayan Ophthalmology Centre, Yerevan, Armenia
Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents
- Conditions
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 39
- Registration Number
- NCT01252888
- Locations
- π¦π²
S.V. Malayna's Ophthalmology Centre, Yerevan, Armenia
Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 119
- Registration Number
- NCT01252849
- Locations
- π¦π²
S.V. Malayan's Ophthalmology Centre, Yerevan, Armenia
Feasibility Study of the Vedera KXS for Treatment of Keratoconus
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 23
- Registration Number
- NCT01069848
- Locations
- πΉπ·
Beyoglu Eye Hospital, Istanbul, Turkey
GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma
- Conditions
- Interventions
- First Posted Date
- 2010-01-20
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 164
- Registration Number
- NCT01052558
- Locations
- πΊπΈ
St. John's Medical Research Institute, Springfield, Missouri, United States
πΊπΈLas Vegas Physician Research Group, Henderson, Nevada, United States
πΊπΈChicago Eye Specialists, Chicago, Illinois, United States
Clinical Evaluation of the Vedera KXS for the Treatment of Spherical Myopia
- First Posted Date
- 2009-06-19
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT00925041
- Locations
- πΉπ·
Beyoglu Eye Research and Education Hospital, Istanbul, Turkey
A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2015-05-20
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 112
- Registration Number
- NCT00911924
- Locations
- π¦πΉ
Allgemeines Krankenhaus Wien, Wien, Austria
π©πͺKnapschaftskrankenhaus Bochum Langendreer, Bochum, Germany
π«π·Hopital Saint-Joseph, Paris, France
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
- Conditions
- Interventions
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2015-05-20
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 192
- Registration Number
- NCT00913029
- Locations
- π¦π²
SV Malayan Ophthalmological Center, Yerevan, Armenia
π¬π·AHEPA Hospital, Thessaloniki, Greece
πͺπΈHospital Torrevieja Salud, UTE, Alicante, Spain
Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract
- Conditions
- Interventions
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Glaukos Corporation
- Target Recruit Count
- 62
- Registration Number
- NCT00721968